VSTM - Verastem stock rallies on positive data for pancreatic cancer drug combo May, 23 2024 06:14 PM Verastem Inc. 2024-05-23 18:14:04 ET More on Verastem Verastem gets FDA orphan drug status for low-grade ovarian cancer therapy Seeking Alpha’s Quant Rating on Verastem Historical earnings data for Verastem Financial information for Verastem For further details see: Verastem stock rallies on positive data for pancreatic cancer drug combo